We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Protherics (MM) | NASDAQ:PTIL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.30 | 0 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
28 October 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange
Act of 1934.
Yes No X
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .
The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PROTHERICS PLC |
||||||||
Date: 28 October 2008 |
By: |
/s/ Rolf Soderstrom |
||||||
Rolf Soderstrom |
||||||||
Finance Director |
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 28
October 2008 -
Protherics PLC ("Protherics" or the "Company"), the
international biopharmaceutical company
focused on critical care and cancer, announces that the following notification of
interest in the ordinary share capital of the Company was
received today
from Aviva plc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered Holder:
BNY Norwich Union
Chase GA Group
Chase Nominees Limited
CUIM Nominee Limited
Vidacos Nominees Limited
*denotes direct interest
BNP Paribas - London
Chase Nominees Limited
State Street Nominees Limited
Vidacos Nominees
|
|
|
|
|
|
|
|
|
|
|
|
|
A: Voting rights attached to shares |
|||||||
Class/type of shares
if possible using
|
Situation
previous
|
Resulting situation after the triggering transaction |
|||||
Number
|
Number
|
Number
of
|
Number of
voting
|
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
Ordinary Shares GB0007029209 |
|
46,722,061
|
30,988,826 |
|
14,982,340 |
|
|
B: Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial
|
Expiration
|
Exercise/
|
Number of
voting
|
% of
voting
|
N/A
|
||||
|
Total (A+B) |
|
Number of voting rights |
% of voting rights |
|
|
8. Chain of controlled undertakings through which the
voting rights and/or the financial
|
The voting rights are managed and controlled by
Aviva Investors Global Services Limited, with the
Aviva Investors Global Services Limited:
|
Proxy Voting: |
|
|
|
|
|
|
|
12. Additional information: |
Figures
are based on a revised total number of
|
| Ends |
For further information please contact:
Protherics |
|
Nick Staples, Director of Corporate Affairs |
+44 (0) 7919 480510 |
Julie Vickers, Company Secretary |
+44 (0)1928 518010 |
|
|
Financial Dynamics - press enquiries |
|
London: Ben Atwell, Lara Mott |
+44 (0) 20 7831 3113 |
New York: John Capodanno |
+1 212 850 5600 |
Or visit www.protherics.com
1 Year Protherics Chart |
1 Month Protherics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions